Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Transurgical Begins HIFU AF Ablation Safety Study, Projects ’05 Pivotal Trial

This article was originally published in The Gray Sheet

  • News

Executive Summary

Transurgical expects to start a 110-patient, 10-site pivotal trial by early 2005 to support a premarket approval application for its HIFU ablation catheter

You may also be interested in...



St. Jude Bolsters AF Offerings Through HIFU, ProRhythm Purchase Option

St. Jude Medical could add a minimally invasive high-intensity focused ultrasound (HIFU) ablation therapy system to its fledgling atrial fibrillation unit under an agreement with developer ProRhythm

St. Jude Bolsters AF Offerings Through HIFU, ProRhythm Purchase Option

St. Jude Medical could add a minimally invasive high-intensity focused ultrasound (HIFU) ablation therapy system to its fledgling atrial fibrillation unit under an agreement with developer ProRhythm

Catheter Ablation Trial Criteria For AF Therapy Clarified In FDA Guidance

Commercialization of CryoCath's catheter ablation system to treat atrial fibrillation could be delayed up to six months due to FDA follow-up data recommendations

Table

View full table

Tags:
Latest Headlines

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

See All
UsernamePublicRestriction

Register

MT020209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By